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Background: Depressive and anxiety disorders are highly overlapping, heterogeneous conditions that
both have been associated with an increased risk of cardiovascular disease (CVD). Cognitive vulner-
ability traits for these disorders could help to specify what exactly drives CVD risk in depressed and
anxious subjects. Our aim is to examine sensitivity to depression or anxiety in association with
indicators of subclinical CVD.
Methods: Data from 635 participants (aged 20–66 years) of the Netherlands Study of Depression and
Anxiety were analyzed. Depression sensitivity was measured by the revised Leiden Index of Depression
Sensitivity. Anxiety sensitivity was measured by the Anxiety Sensitivity Index. Subclinical CVD was
measured as (1) carotid intima-media thickness and plaque presence using B-mode ultrasonography
and (2) central arterial stiffness (augmentation index) using calibrated radial applanation tonometry.
Results: After adjustment for sociodemographics, blood pressure, and LDL cholesterol, higher scores of
anxiety sensitivity were associated with both increased likelihood of carotid plaques (OR per SD
increase¼1.34, 95%CI¼1.06–1.68) and increased arterial stiffness (b¼ .06, p¼ .01). No signiﬁcant
associations were found with carotid intima-media thickness nor for depression sensitivity.
Limitations: The cross-sectional design precludes causal inference. Current mood state could have
inﬂuenced the self-reported sensitivity data.
Conclusions: The presence of carotid plaques and central arterial stiffness was especially increased in
subjects who tend to be highly fearful of anxiety-related symptoms. These observations suggest that
vulnerability to anxiety, rather than to depression, represents a correlate of subclinical CVD.
& 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Depression and anxiety have both been associated with an
increased risk of subclinical (Lavoie et al., 2010; Seldenrijk et al.,
2011a; Tiemeier et al., 2004) and overt (Nicholson et al., 2006;
Roest et al., 2010) cardiovascular disease (CVD). Comparison of
the effect sizes of two meta-analyses would suggest that depres-
sion (pooled RR¼1.81 (Nicholson et al., 2006)) more than anxiety
(pooled HR¼1.26 (Roest et al., 2010)) is associated with increased
CVD risk. However, since most studies focus on either depression
or anxiety, it is impossible to properly compare their respectiveraat 1187, 1081 HL Amster-
31 20 788 5664.
denrijk).
sevier OA license.contribution to CVD risk. The heterogeneity of clinical diagnoses
further complicates the disentangling of CVD risk in depression
and anxiety, since symptoms (Hiller et al., 1989) and occurrence
(Kessler et al., 2005) of these psychiatric syndromes are largely
overlapping. Because emotional distress likely exerts its effects on
the arteries in a cumulative manner, it may be worthwhile to
study the clustering of mental and vascular disease at the level of
cognitive vulnerability to depression or anxiety.
Dysfunctional cognitions are thought to contribute to the
development and maintenance of depressive and anxiety disor-
ders. The ‘gold standard’ psychotherapy therefore is based on the
idea that information processing is disturbed in depression
(negative view of self, world and future) and anxiety (over-
estimation of danger and risk). Several ‘cognitive’ characteristics
have been closely linked to depression, such as hopelessness,
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2011; Drost et al., 2011; Nolen-Hoeksema, 2000). Anxiety sensi-
tivity refers to the perception that bodily symptoms are harmful
in physical, psychological, or social sense. It is considered a
characteristic preceding the development of anxiety disorders,
and particularly (but not only) panic attacks (Olatunji and
Wolitzky-Taylor, 2009). If the concept of depression is related to
CVD, depression-speciﬁc characteristics would be associated with
CVD. If anxiety, in turn, is a more important risk factor, anxiety-
speciﬁc beliefs in particular would show associations with CVD.
Some studies already have examined these cognitive disposi-
tions in association with cardiovascular outcomes. Both positive
(Everson et al., 1997b; Matthews et al., 1998) and absent (Stewart
et al., 2007) associations were found for hostility and athero-
sclerosis. Hopelessness has been associated with increased ather-
osclerosis (Everson et al., 1997a) and ischemic heart disease
(Anda et al., 1993), but an inverse association was found between
cardiac anxiety (partly covering anxiety sensitivity) and coronary
calciﬁcation (Marker et al., 2008). Previous results thus are
inconclusive of associations between cognitive vulnerability and
CVD risk and a direct comparison between depression- and
anxiety-related characteristics in one population is still lacking.
This study examines cognitive vulnerability to depression and
anxiety in association with carotid atherosclerosis and central
arterial stiffness.2. Methods
2.1. Sample
The present study was conducted as an extension of the 2-year
assessment of the Netherlands Study of Depression and Anxiety
(NESDA), an ongoing longitudinal cohort study examining the
course of depressive and anxiety disorders. Participants were
recruited from community, primary care and outpatient psychia-
tric clinics. The NESDA baseline sample (2004–2007) included
2329 persons with a lifetime depressive and/or anxiety disorder,
and 652 controls, aged 18 through 65 years. Details of the study
rationale, recruitment strategy and methods have been described
elsewhere (Penninx et al., 2008). The research protocol was
approved by the Ethical Committee of participating universities
and all respondents provided written informed consent.
Of the 2981 baseline participants invited, 2596 joined the
2-year assessment. Afterwards, 650 participants underwent addi-
tional cardiovascular measurements (for details of recruitment
strategy, see (Seldenrijk et al., 2011b,, 2011a) of whom 635 had
valid cognitive vulnerability data.
2.2. Psychological characteristics
The revised Leiden Index of Depression Sensitivity (LEIDS-R;
(Van der Does, 2002; Van der Does and Williams, 2003)) assessed
the extent to which dysfunctional cognitions are triggered during
normal mood variations. The LEIDS-R comprises six subscales,
based on 34 items that are answered on a 5-point Likert scale
(0¼ ‘not at all’ to 4¼ ‘very strongly’). Since a previous study (Drost
et al., 2011) has shown that Hopelessness and Rumination are
unique factors in major depressive disorder and Aggression is
unique for dysthymic disorder, only these subscales were
included in the current analyses. Hopelessness consists of 5 items
(e.g., ‘When I feel down, I more often feel hopeless about every-
thing’), with a maximum score of 20. Rumination and Aggression
are each based on 6 items (e.g., ‘When in a sad mood, I more often
think about how my life could have been different’ or ‘When I feel
bad, I more often feel like breaking things’) with maximum scoresof 24. The three subscales showed good internal consistency in
the present sample (all a0s4 .95).
The anxiety sensitivity index (ASI; (Reiss et al., 1986)) was
used to assess the degree to which one is concerned about
possible negative consequences of bodily, cognitive or publicly
observable sensations. The questionnaire includes 16 items,
which are answered on a 5-point Likert scale (0¼ ‘hardly’ to
4¼ ‘very much’), e.g., ‘It scares me when my heart beats rapidly’
or ‘It scares me when I am unable to keep my mind on a task’. The
scale has a maximum score of 64 and showed good internal
consistency in the present sample (a¼ .89).
As expected, strong correlations were found between NESDA
baseline and 2-year assessment scores (LEIDS-R Hopelessness
r¼ .74, Aggression r¼ .65, Rumination r¼76, p-valueso .001; ASI
r¼ .73, po .001). We averaged scores over both assessments in
order to maximize the reliability of these cognitive vulnerability
measures.
2.3. Subclinical cardiovascular disease
Carotid intima-media thickness (CIMT) and plaque presence
were assessed using an Acuson Aspen ultrasound instrument
equipped with a near-ﬁeld L7 linear array 5–10 MHz broadband
transducer (Siemens, Erlangen, Germany). Details on the ultra-
sonography measurement can be found elsewhere (Seldenrijk
et al., 2011b). We used bifurcation CIMT (CIMTbif) as outcome
measure, since bifurcations are particularly prone to progression
of atherosclerosis (Stary et al., 1992). Previous observations in this
relatively young sample indeed have favoured the bifurcation as
predilection segment over total CIMT in terms of sensitivity to
difference (Seldenrijk et al., 2011b).
As described before (Seldenrijk et al., 2011a), we used central
augmentation index normalized for a heart rate of 75 beats per
minute (AIx75) as a measure of arterial stiffness. Ascending aortic
blood pressure waveform was generated, based on radial pressure
waveforms including a generalized transfer function (2000 ver-
sion 7, AtCor Medical, Sydney, Australia) and oscillometrically
determined brachial pressures (DinamapsPRO100, GE Medical
Systems, Tampa, FL).
2.4. Covariates
Sociodemographics included age, sex and education (years).
Additionally, several lifestyle and health factors were assessed at
the time of 2-year assessment or cardiovascular assessment
(average in-between time is 2 months). Blood pressure was
measured at the right arm during supine rest (Seldenrijk et al.,
2011a). Mean arterial pressure (MAP) was calculated as
(2ndiastolic pressureþsystolic pressure)/3. Low density lipopro-
tein (LDL) cholesterol (mmol/l) was determined, based on fasting
blood samples. Body mass index (BMI) was calculated as weight
in kilograms divided by height in meters squared. Smoking status
was deﬁned as non-smoker, former smoker or current smoker.
Physical activity was measured with the International Physical
Activity Questionnaire (Craig et al., 2003) in MET-minutes per
week and categorized as low, medium or high.
Use of antihypertensive or lipid-modifying medication was
based on drug-container inspection of all drugs used in the past
month and classiﬁed according to Anatomical Therapeutic Che-
mical (ATC) coding: C02, C03, C07, C08 and C09 for antihyperten-
sive and C10 for lipid-modifying agents. Type 2 Diabetes
Mellitus was based on fasting glucose levels Z7 mmol/l or use
of blood-glucose lowering medication [ATC code A10]. CVD
(including myocardial infarction, stroke, angina-pectoris, percu-
taneous transluminal coronary angioplasty and coronary artery
bypass grafting) was adjudicated using standardized algorithms
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2010). Since we previously found no straight-forward associations
between the use of antidepressant medication and subclinical
CVD (Seldenrijk et al., 2011b, 2011a), we did not include anti-
depressants among the covariates in the current analyses.
2.5. Statistical analyses
First, linear regression analyses (for continuous subclinical
CVD outcomes) and logistic regression analyses (for dichotomous
outcomes) adjusted for sociodemographics, blood pressure and
LDL cholesterol (model 1) were conducted to assess associations
with depression or anxiety sensitivity. Analyses were additionally
adjusted for lifestyle factors (BMI, smoking and physical activity;
model 2). In case of signiﬁcant associations, and in order to rule
out the possibility that any observed relationship was driven by
subjects with known or suspected cardiovascular health (i.e., CVD,
diabetes, use of antihypertensive/ lipid-modifying medication),
model 1 analyses were repeated without those cases.3. Results
3.1. Sample characteristics
Characteristics of the 635 participants are presented in Table 1.
The mean age was 46.7712.0 years and 65.5% was female. A
strong correlation between psychological factors was found for
hopelessness and rumination (r¼ .82, po .001), but less strong
correlations existed for other factors (anxiety sensitivity and
aggression, r¼ .38; anxiety sensitivity and hopelessness or rumi-
nation, r¼ .51; rumination and aggression, r¼ .59).
3.2. Cognitive vulnerability and subclinical CVD
Table 2 shows results of regression analyses for carotid
atherosclerosis and central arterial stiffness. No signiﬁcant asso-
ciations were found for depression sensitivity, though a tendency
was seen for aggression reactivity to be associated with carotid
plaque. No signiﬁcant associations were observed between any
cognitive vulnerability factor and CIMTbif. Subjects scoring higher
on anxiety sensitivity, however, had a higher likelihood of plaque
presence and showed increased arterial stiffness. Additional
adjustment for BMI, smoking and physical activity hardly inﬂu-
enced the associations (plaque: ORAgression¼1.22, 95%CI¼0.97–
1.54; ORASI¼1.30, 95%CI¼1.03–1.65; AIx75: bASI¼ .05, p¼ .04);
neither did correction for the use of antidepressant medication
(not shown).
To check whether signiﬁcant associations were driven by
subjects with known or suspected cardiovascular health, analyses
were repeated without those cases. Associations among healthy
subjects were even stronger: higher anxiety sensitivity was
associated to more carotid plaques (n¼46/488; OR per SD
increase¼1.49, 95%CI¼1.09–2.03, p¼ .01) and increased stiffness
(n¼481; b¼ .08, p¼ .01). Furthermore, the trend for increased
plaque presence in subjects scoring high on aggression reactivity
gained strength (OR¼1.34, 95%CI¼0.99–1.81; p¼ .06).
3.3. Post-hoc analyses
Additional 5000 estimates bootstrapping analyses (Preacher
and Hayes, 2008) were conducted to evaluate whether associa-
tions for anxiety sensitivity were independent of psychopathol-
ogy, since we previously found that current depression or anxiety
(highly characterized by lifetime comorbidity) was associated
with increased AIx (Seldenrijk et al., 2011a). Fig. 1 shows theresults of mediation models in which the ASI and psychopathol-
ogy (sum of lifetime diagnoses) were entered while controlling
for model 1 covariates. These results indicate that psychopathol-
ogy partly mediates the association between ASI and increased
arterial stiffness.4. Discussion
When studying increased cardiovascular risk associated with
psychopathology, clinical diagnoses have the disadvantage of
being broad concepts, that include much heterogeneity, high
comorbidity and overlapping symptoms. We therefore investi-
gated associations between subclinical CVD and cognitive vulner-
ability to depression or anxiety in a sample of subjects with
lifetime depressive or anxiety disorders and controls. We found
that carotid plaque presence and central arterial stiffness were
especially increased in subjects who tend to be highly fearful of
anxiety-related bodily sensations. No signiﬁcant associations
were found with CIMT as the outcome, nor for any of the
depression sensitivity measures.
Our observation that anxiety sensitivity more than depression
sensitivity represents a correlate of subclinical CVD is in close
agreement with some previous observations that anxiety disor-
ders rather than depressive disorders are associated with cor-
onary heart disease (Janszky et al., 2010; Vogelzangs et al., 2010).
The notion that anxiety-proneness increases the risk of carotid
atherosclerosis has been supported previously (Paterniti et al.,
2001). Anxiety sensitivity itself has hardly been studied in
association with cardiovascular outcomes. We found only one
study that examined cardiac anxiety (using the Cardiac Anxiety
Questionnaire) in 658 subjects who received EBT screening for
determining the presence of coronary calciﬁcation (Marker et al.,
2008). In contrast with our observations, this study showed
higher rates of heart focused attention and worry to be associated
with the absence of coronary calciﬁcation. However, the popula-
tion included both self-referred and physician-referred partici-
pants, which potentially has inﬂuenced this counterintuitive
ﬁnding. The authors state that their observation is ‘‘consistent
with what could be expected from individuals who are overly
focused on health related concerns’’. Although overestimation of
danger indeed is a cognitive error associated with anxiety, this
does not mean that fear of anxiety-related bodily sensations
should be ignored in the cardiovascular realm. For example, it
recently has been shown that (high) anxiety sensitivity is a
psychological factor that makes prognostic difference in atrium
ﬁbrillation and congestive heart failure and should be taken into
account in the choice of treatment (Frasure-Smith et al., 2010).
Apart from a suggestive ﬁnding for aggression, none of the
depression sensitivity measures were associated with subclinical
CVD in our sample. The trend we observed for aggression –
indicating that a higher aggression reactivity was associated with
an increased odds for carotid plaque – is in line with a study that
found hostile attitudes to be predictive of carotid atherosclerosis
(Matthews et al., 1998). This cardiotoxic inﬂuence of hostility has
also been conﬁrmed by a meta-analysis (Chida and Steptoe,
2009).
A notable inconsistency is the difference seen for ultrasono-
graphic phenotypes of carotid atherosclerosis: unlike plaque
presence, CIMTbif shows no signiﬁcant association with anxiety
sensitivity. CIMT and plaque are both considered indicators of
atherosclerosis (de Groot et al., 2004; Wyman et al., 2005) and, as
such, would be expected to show a similar relationship with
anxiety sensitivity. One explanation for the divergent ﬁndings
could be that CIMTbif is not associated with CVD in a continuous
way throughout its full range and that plaque is qualitatively
Table 1
Sample characteristics (N¼635).
Mean (SD)
or %
Sociodemographics
Age, years 46.7 (12.0)
Sex, female 65.5
Education, years 12.8 (3.2)
Lifestyle and health indicators
Body mass index, (kg/m2) 25.4 (4.6)
Smoking status
Never 30.7
Former 43.1
Current 26.1
Physical activity level
Low 17.6
Moderate 47.1
High 35.3
Systolic blood pressure, (mmHg) 114.2
(15.1)
Diastolic blood pressure, (mmHg) 67.9 (9.3)
Mean arterial blood pressure, (mmHg) 83.3 (10.5)
LDL cholesterol, (mmol/l) 2.99 (0.88)
Use of antihypertensive agents 18.6
Use of lipid-modifying agents 7.6
Diabetes mellitus (type 2) 4.3
Cardiovascular disease 7.9
Psychiatric characteristics
Psychopathology status, lifetime
Controls 27.9
Depressive disorder(s) only 14.6
Anxiety disorder(s) only 11.2
Depressive and anxiety disorders 46.3
Type of depressive or anxiety disorder, lifetime
Major depressive disorder 58.9
Dysthymic disorder 24.7
Panic disorder 30.6
Agoraphobia 12.1
Social phobia 32.1
General anxiety disorder 29.6
Sum of lifetime depression and anxiety diagnoses, median
(IQR)
2 (3)
Use of antidepressant medication 16.5
Cognitive vulnerability factors
Depression sensitivity (LEIDS-R)
Hopelessness reactivity 4.11 (4.00)
Aggression reactivity 4.07 (3.49)
Rumination on sadness 8.43 (4.92)
Anxiety sensitivity (ASI) 12.7 (8.4)
Markers of subclinical cardiovascular disease
Carotid bifurcation intima-media thickness, (mm) 0.75 (0.21)
Carotid plaque 14.6
Central augmentation index corrected for heart rate,
percentage
14.3 (14.7)
ASI¼anxiety sensitivity index; IQR¼ inter-quartile range; LEIDS-R¼Leiden inven-
tory of depression sensitivity, revised; LDL¼ low density lipoprotein.
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(Ebrahim et al., 1999). Arguing against this, however, is the fact
that we have found similar associations for CIMT and plaque with
respect to age of depression onset (Seldenrijk et al., 2011b).
Previous analyses in the current sample focused on associa-
tions between depressive or anxiety disorders and subclinical
CVD. We had found depressive and anxiety disorders to be
associated with increased arterial stiffness (Seldenrijk et al.,
2011a). Mediation analyses were conducted in order to investi-
gate whether this ﬁnding was interrelated to the currently
observed association for anxiety sensitivity. Our results suggest
that anxiety sensitivity indeed might uncover one of the under-
lying dimensions responsible for the increased stiffness pre-
viously found in subject with current depressive or anxiety
disorders. With respect to carotid plaque, we earlier observedno signiﬁcant association with diagnoses of depressive or anxiety
disorders (Seldenrijk et al., 2011b). Based on observations in the
current study, the continuous concept of cognitive vulnerability
to anxiety appears to be a more sensitive correlate of carotid
plaques than dichotomous and more heterogeneous diagnoses.
Which are potential mechanisms responsible for the increased
carotid plaque presence and central arterial stiffness found in
subjects who are highly fearful of anxiety-related sensations?
Anxiety sensitivity and CVD are both strongly inheritable (Lloyd-
Jones et al., 2004; Stein et al., 1999) and might share a genetic
basis. Lifestyle factors could also provide an explanation for
increased CVD risk since anxiety sensitivity has been linked with
risk-promoting behaviours (Brown et al., 2001; Smits and
Zvolensky, 2006). However, observed associations in this study
were independent of BMI, smoking and physical activity. The
arousal associated with high anxiety sensitivity could as well
exert its effects through systemic pro-inﬂammatory state or
released stress-hormones. Immune system abnormalities indeed
have been found in subjects with panic disorder and post-
traumatic stress disorder (Hoge et al., 2009). Previous observa-
tions in NESDA seem to object to the stress-hormone idea, since
anxiety sensitivity was found to be unrelated to salivary cortisol
levels (Van Santen et al., 2011). In case of reverse causality,
subclinical CVD would elicit certain symptoms that enhance
anxiety sensitivity. This explanation is possible though not very
likely, because exclusion of subjects with a compromised cardi-
ovascular status (CVD, diabetes, use of antihypertensive/lipid-
modifying agents) did not weaken associations.
To our knowledge this is the ﬁrst study to investigate associa-
tions between sensitivity to either depressive or anxiety disorders
and subclinical CVD outcomes measured by using state-of-the-art
techniques. The ﬁndings should be viewed in the context of the
study’s limitations. Because of the study’s cross-sectional design,
the causal nature of the associations between anxiety sensitivity
and subclinical CVD remains unsolved. Prospective evidence is
needed to examine whether anxiety sensitivity (e.g., through
physiological arousal accompanying the fear of anxiety-related
sensations) indeed is responsible for the deleterious arterial
conditions. Since the sample size was not very large, it is possible
that a low statistical power has led to small effects or even to
ignoring an existing association (Type II error). Besides, the self-
report sensitivity measures could have been inﬂuenced by the
current mood status, so that report bias might have taken place.
However, correlations between the NESDA baseline and 2-year
scores were high despite changes in psychopathology status that
have occurred. Furthermore, it would have been interesting to
examine dimensions of anxiety sensitivity in association with
subclinical CVD, but the questionnaire version used in NESDA
((ASI) (Reiss et al., 1986)) is held psychometrically unsuitable for
these purposes (Olatunji and Wolitzky-Taylor, 2009).
Anxiety sensitivity now has been presented as a psychological
characteristic capable of detecting subjects at increased cardio-
vascular risk. Because anxiety often overlaps depression in pre-
valence and symptoms, cardiovascular research needs to be
paying attention to the two at one go. For general practice and
other primary health care services, implications might include
detection of subjects who are highly fearful of bodily sensations
and referral for psychological interventions (e.g., cognitive beha-
vioural therapy) or prescriptive exercise, both of which have
shown to successfully reduce anxiety sensitivity (Smits et al.,
2008b,, 2008a). Although this deserves proper research, in doing
so, the increased CVD risk associated with depressive and anxiety
disorders could be potentially alleviated. Since our ﬁndings
suggest that cognitive vulnerability to anxiety, rather than
depression sensitivity, is associated with indicators of increased
cardiovascular risk, it seems important to widen the habitual
Table 2
Associations between cognitive vulnerability factors and subclinical CVD.
Carotid atherosclerosis Arterial stiffness
CIMTbif Plaque AIx75
N¼629 N¼634 N¼605
b p ORn 95%CI p b p
Depression sensitivity
Hopelessness reactivity  .02 .52 0.97 0.76–1.24 .82 .03 .18
Aggression reactivity .04 .15 1.24 0.98–1.56 .07 .01 .69
Rumination on sadness  .01 .65 1.06 0.83–1.36 .64 .02 .34
Anxiety sensitivity .02 .41 1.34 1.06–1.68 .01 .06 .01
Model 1 associations adjusted for age, sex, education, blood pressure (athero-
sclerosis: systolic; stiffness: mean arterial), LDL cholesterol.
CIMTbif¼carotid bifurcation intima-media thickness; AIx75¼ central augmenta-
tion index corrected for heart rate; LDL¼ low density lipoprotein.
n Odds ratio’s are per SD increase in cognitive vulnerability score.
ASI
Depressive and 
anxiety disorders 
AIx75c’ = .03 (.05), ns 
[c =.11 (.04), p=.01]
a = .11 (.01), p ,)72.(37.=b100.< p=.01 
Fig. 1. Effect of anxiety sensitivity on arterial stiffness, mediated by psycho-
pathology. Model 1 associations adjusted for age, sex, education, mean arterial
pressure, LDL cholesterol. a¼effect of ASI on psychopathology; b¼effect of
psychopathology on stiffness independent of ASI; c0 ¼direct effect of ASI on
stiffness; c¼total effect of ASI on stiffness (c0 þab). ASI¼anxiety sensitivity index;
Aix75¼central augmentation index corrected for heart rate; LDL¼ low density
lipoprotein.
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